Journals / Türk Nöroloji Dergisi / 2018 / Cilt: 24 - Sayı: 4

Intravenous Lidocain in SUNCT Treatment

SUNCT’ta İntravenöz Lidokain Kulla

Pages
337–339
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a patient treated with IV lidocaine during an acute episode that gained sustained remission.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SUNCT/SUNA are rare, severe, neuralgiform headaches with high frequency.
📊
Key Findings & Data:They are often considered as a primary headache type.
💡
Conclusion & Impact:Here, we present a patient treated with IV lidocaine during an acute episode that gained sustained remission.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

SUNCT/SUNA are rare, severe, neuralgiform headaches with high frequency. They are often considered as a primary headache type. It is called episodic or chronic according to the peridiocity. At the time of attack, it can affect the daily life of the patient such that it can keep the patient from oral feeding. Therefore, it is specifically important to relieve the pain of the patient during the headache episode. Here, we present a patient treated with IV lidocaine during an acute episode that gained sustained remission.

Özet

SUNCT/SUNA nadir görülen, şiddetli, nevraljiform karakterde, frekansı yüksek, çoğu zaman primer bir baş ağrısı türüdür. Görülme zamanına göre epizodik ve kronik form olarak ayrılmaktadır. Atak zamanında hastanın günlük yaşamını oral beslenemeyecek kadar etkileyebilmektedir. Bu nedenle özellikle atak döneminde hastanın ağrısının hızla giderilmesi önemlidir. Biz burada günlük yaşamı ağrı nedeniyle oldukça etkilenmiş atak dönemindeki bir hastada intravenöz lidokain ile elde edilen uzamış remisyonu göstermeyi amaçladık.

🔖

Cite This Article

İNAN, L. E., KOCATÜRK, M., KOCATÜRK, Ö. (2022). Intravenous Lidocain in SUNCT Treatment. Türk Nöroloji Dergisi, Cilt: 24 - Sayı: 4, 337–339. https://ajindex.com/articles/636791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808. Cohen AS. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia 2007;27:824-832.
  2. Weng HY, Cohen AS, Schankin C, Goadsby PJ. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebocontrolled trial Cephalalgia 2018:38:1554-1568.
  3. Arroyo AM, Durán XR, Beldarrain MG, Pinedo A, García-Moncó JC. Response to intravenous lidocaine in a patient with SUNCT syndrome. Cephalalgia 2010;30:110-112. UpToDate Erişim tarihi: 9 Şubat 2018. Available from: http://www.who. int Uptodate.com/contents/short-lasting-unilateral-neuralgiform-headacheattacks- treatment